These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34937245)

  • 1. Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes.
    Jethani J
    Indian J Ophthalmol; 2022 Jan; 70(1):238-240. PubMed ID: 34937245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of myopia onset with 0.025% atropine in premyopic children.
    Fang PC; Chung MY; Yu HJ; Wu PC
    J Ocul Pharmacol Ther; 2010 Aug; 26(4):341-5. PubMed ID: 20698798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low Dose Atropine in Preventing the Progression of Childhood Myopia: A Randomised Controlled Trial.
    Sharma I; Das GK; Rohatgi J; Sahu PK; Chhabra P; Bhatia R
    Curr Eye Res; 2023 Apr; 48(4):402-407. PubMed ID: 36576170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comment on: Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes.
    Patil AA; Murthy SR
    Indian J Ophthalmol; 2022 May; 70(5):1852. PubMed ID: 35502098
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to comment on: Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes.
    Jethani J
    Indian J Ophthalmol; 2022 May; 70(5):1853. PubMed ID: 35502099
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control.
    Yam JC; Jiang Y; Tang SM; Law AKP; Chan JJ; Wong E; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
    Ophthalmology; 2019 Jan; 126(1):113-124. PubMed ID: 30514630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myopia progression and axial elongation in Spanish children: Efficacy of atropine 0.01% eye-drops.
    Moriche-Carretero M; Revilla-Amores R; Diaz-Valle D; Morales-Fernández L; Gomez-de-Liaño R
    J Fr Ophtalmol; 2021 Dec; 44(10):1499-1504. PubMed ID: 34774348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective analysis of the therapeutic effects of 0.01% atropine on axial length growth in children in a real-life clinical setting.
    Kaymak H; Graff B; Schaeffel F; Langenbucher A; Seitz B; Schwahn H
    Graefes Arch Clin Exp Ophthalmol; 2021 Oct; 259(10):3083-3092. PubMed ID: 34142186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of treatment response about low-dose (0.01%) atropine eye-drops in myopic children.
    Jeon GS; Hong IH; Lee JH; Song TG; Lee TY; Han JR
    Eur J Ophthalmol; 2022 Jul; 32(4):2011-2017. PubMed ID: 34399596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Low-Dose Atropine Eyedrops for the Treatment of Myopia Progression in Chinese Children: A Randomized Clinical Trial.
    Wei S; Li SM; An W; Du J; Liang X; Sun Y; Zhang D; Tian J; Wang N
    JAMA Ophthalmol; 2020 Nov; 138(11):1178-1184. PubMed ID: 33001210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of 1% atropine eye drops in retarding progressive axial myopia in Indian eyes.
    Kothari M; Rathod V
    Indian J Ophthalmol; 2017 Nov; 65(11):1178-1181. PubMed ID: 29133646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of atropine 0.01% on progression of myopia.
    Sen S; Yadav H; Jain A; Verma S; Gupta P
    Indian J Ophthalmol; 2022 Sep; 70(9):3373-3376. PubMed ID: 36018124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: low-dose atropine and myopia progression.
    Fu A; Stapleton F; Wei L; Wang W; Zhao B; Watt K; Ji N; Lyu Y
    Br J Ophthalmol; 2020 Nov; 104(11):1535-1541. PubMed ID: 32086237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-term results of using low-concentration atropine eye drops for controlling myopia progression in schoolchildren.
    Wu PC; Yang YH; Fang PC
    J Ocul Pharmacol Ther; 2011 Oct; 27(5):461-6. PubMed ID: 21815829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical atropine in retarding myopic progression and axial length growth in children with moderate to severe myopia: a pilot study.
    Fan DS; Lam DS; Chan CK; Fan AH; Cheung EY; Rao SK
    Jpn J Ophthalmol; 2007; 51(1):27-33. PubMed ID: 17295137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age Effect on Treatment Responses to 0.05%, 0.025%, and 0.01% Atropine: Low-Concentration Atropine for Myopia Progression Study.
    Li FF; Zhang Y; Zhang X; Yip BHK; Tang SM; Kam KW; Young AL; Chen LJ; Tham CC; Pang CP; Yam JC
    Ophthalmology; 2021 Aug; 128(8):1180-1187. PubMed ID: 33422558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive effects of orthokeratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: first year results.
    Kinoshita N; Konno Y; Hamada N; Kanda Y; Shimmura-Tomita M; Kakehashi A
    Jpn J Ophthalmol; 2018 Sep; 62(5):544-553. PubMed ID: 29974278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Low-Concentration Atropine Eyedrops vs Placebo on Myopia Incidence in Children: The LAMP2 Randomized Clinical Trial.
    Yam JC; Zhang XJ; Zhang Y; Yip BHK; Tang F; Wong ES; Bui CHT; Kam KW; Ng MPH; Ko ST; Yip WWK; Young AL; Tham CC; Chen LJ; Pang CP
    JAMA; 2023 Feb; 329(6):472-481. PubMed ID: 36786791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive effects of orthokeratology and atropine 0.01% eye drops on slowing the progression of myopia.
    Zhou H; Zhao G; Li Y
    Clin Exp Optom; 2022 Jul; 105(5):520-526. PubMed ID: 34228946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Effects on Ocular Biometrics by 0.05%, 0.025%, and 0.01% Atropine: Low-Concentration Atropine for Myopia Progression Study.
    Li FF; Kam KW; Zhang Y; Tang SM; Young AL; Chen LJ; Tham CC; Pang CP; Yam JC
    Ophthalmology; 2020 Dec; 127(12):1603-1611. PubMed ID: 32525048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.